Injectable Hydrogen Gel Reduces Joint Damage in Arthritis Study
- Authors
- Wenjing Zhang, Lingting Zeng, Huan Yu, Ziheng He, Cuishan Huang, Cairong Li, Yangyi Nie, Long Li, Feifei Zhou, Ben Liu, Yuantao Zhang, Zhenyu Yao, Wei Zhang, Ling Qin, Di Chen, Qianjun He, Yuxiao Lai
- Journal
- Acta Biomaterialia
- Year
- 2022
- DOI
- 10.1016/j.actbio.2022.12.056
- Study Type
- Rat
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Osteoarthritis
- Body System
- Musculoskeletal
TL;DR
Scientists developed a special gel that releases hydrogen gas to reduce inflammation and slow down the damage in joints caused by osteoarthritis when injected just once.
Key Finding
An injectable hydrogel loaded with calcium boride nanoparticles released hydrogen gas for over one week and significantly reduced joint destruction in osteoarthritis rat models with a single injection.
Summary
Researchers developed an injectable gel containing calcium boride nanoparticles that slowly releases hydrogen gas directly into the joint. In rat studies, this gel reduced harmful molecules called reactive oxygen species and inflammatory chemicals that damage joints in osteoarthritis, while promoting protective immune cells. A single injection significantly reduced joint damage in arthritic rats over the study period.
Practical Takeaway
This is early-stage research in animals only, not yet tested in humans. While the results suggest hydrogen gas delivery via this gel formulation may help reduce osteoarthritis progression, much more research is needed before any clinical use. The sustained-release approach is novel, but its safety and effectiveness in people remain unknown.
Abstract (excerpt)
Excessive production of reactive oxygen species (ROS) amplifies pro-inflammatory pathways and exacerbates immune responses, and is a key factor in the progression of osteoarthritis (OA). Therapeutic hydrogen gas (H2) with antioxidative and anti-inflammatory effects, has a potential for OA…